Stefan J Jodl

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Inflammatory Response

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)
Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)
Stefan J Jodl, Wouter Ten Voorde, Stefan Klein, Andrea Wagenfeld, Frank S Zollmann, Maximilian Feldmüller, Naomi B Klarenbeek, Digna T de Bruin, Manon A A Jansen, Robert Rissmann, Beate Rohde, Matthijs Moerland
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers. Clinical and translational science 17 (3) (2024)